Avantax Valuation
Is AVTA undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of AVTA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate AVTA's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate AVTA's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for AVTA?
Key metric: As AVTA is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is AVTA's PS Ratio? | |
|---|---|
| PS Ratio | 1.3x |
| Sales | US$729.64m |
| Market Cap | US$957.11m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.6x |
| Enterprise Value/EBITDA | 15.4x |
| PEG Ratio | 21.7x |
Price to Sales Ratio vs Peers
How does AVTA's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 16x | ||
BSIG BrightSphere Investment Group | 2.5x | 8.7% | US$1.1b |
NOAH Noah Holdings | 2x | 5.3% | US$780.4m |
AC Associated Capital Group | 56.6x | n/a | US$777.9m |
GAMI GAMCO Investors | 2.8x | n/a | US$629.5m |
AVTA Avantax | 1.3x | 9.0% | US$957.1m |
Price-To-Sales vs Peers: AVTA is good value based on its Price-To-Sales Ratio (1.3x) compared to the peer average (17.5x).
Price to Sales Ratio vs Industry
How does AVTA's PS Ratio compare vs other companies in the US Capital Markets Industry?
Price-To-Sales vs Industry: AVTA is good value based on its Price-To-Sales Ratio (1.3x) compared to the US Capital Markets industry average (2.8x).
Price to Sales Ratio vs Fair Ratio
What is AVTA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 1.3x |
| Fair PS Ratio | 1.5x |
Price-To-Sales vs Fair Ratio: AVTA is good value based on its Price-To-Sales Ratio (1.3x) compared to the estimated Fair Price-To-Sales Ratio (1.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | n/a | US$28.00 0% | 7.1% | US$30.00 | US$26.00 | n/a | 2 |
| Nov ’25 | n/a | US$28.00 0% | 7.1% | US$30.00 | US$26.00 | n/a | 2 |
| Oct ’25 | n/a | US$28.00 0% | 7.1% | US$30.00 | US$26.00 | n/a | 2 |
| Sep ’25 | n/a | US$28.00 0% | 7.1% | US$30.00 | US$26.00 | n/a | 2 |
| Aug ’25 | n/a | US$28.00 0% | 7.1% | US$30.00 | US$26.00 | n/a | 2 |
| Jul ’25 | n/a | US$28.00 0% | 7.1% | US$30.00 | US$26.00 | n/a | 2 |
| Jun ’25 | n/a | US$28.00 0% | 7.1% | US$30.00 | US$26.00 | n/a | 2 |
| May ’25 | n/a | US$28.00 0% | 7.1% | US$30.00 | US$26.00 | n/a | 2 |
| Apr ’25 | n/a | US$28.00 0% | 7.1% | US$30.00 | US$26.00 | n/a | 2 |
| Mar ’25 | n/a | US$28.00 0% | 7.1% | US$30.00 | US$26.00 | n/a | 2 |
| Feb ’25 | n/a | US$28.00 0% | 7.1% | US$30.00 | US$26.00 | n/a | 2 |
| Jan ’25 | n/a | US$28.00 0% | 7.1% | US$30.00 | US$26.00 | n/a | 2 |
| Dec ’24 | US$25.99 | US$28.00 +7.7% | 7.1% | US$30.00 | US$26.00 | n/a | 2 |
| Nov ’24 | US$25.83 | US$28.00 +8.4% | 7.1% | US$30.00 | US$26.00 | n/a | 2 |
| Oct ’24 | US$25.58 | US$28.00 +9.5% | 7.1% | US$30.00 | US$26.00 | n/a | 2 |
| Sep ’24 | US$21.11 | US$29.00 +37.4% | 4.9% | US$30.00 | US$27.00 | n/a | 3 |
| Aug ’24 | US$25.65 | US$31.17 +21.5% | 5.0% | US$32.50 | US$29.00 | n/a | 3 |
| Jul ’24 | US$22.38 | US$31.17 +39.3% | 5.0% | US$32.50 | US$29.00 | n/a | 3 |
| Jun ’24 | US$21.21 | US$31.17 +46.9% | 5.0% | US$32.50 | US$29.00 | n/a | 3 |
| May ’24 | US$25.51 | US$33.33 +30.7% | 3.7% | US$35.00 | US$32.00 | n/a | 3 |
| Apr ’24 | US$26.32 | US$34.00 +29.2% | 2.4% | US$35.00 | US$33.00 | n/a | 3 |
| Mar ’24 | US$28.50 | US$34.00 +19.3% | 2.4% | US$35.00 | US$33.00 | n/a | 3 |
| Feb ’24 | US$29.10 | US$29.00 -0.3% | 10.2% | US$32.00 | US$25.00 | n/a | 3 |
| Jan ’24 | US$25.53 | US$29.00 +13.6% | 10.2% | US$32.00 | US$25.00 | n/a | 3 |
| Dec ’23 | US$25.06 | US$29.00 +15.7% | 10.2% | US$32.00 | US$25.00 | US$25.99 | 3 |
| Nov ’23 | US$23.37 | US$26.00 +11.3% | 12.6% | US$30.00 | US$22.00 | US$25.83 | 3 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
International Money Express
US$659.3m
Operates as an omnichannel money remittance services company in the United States, Latin America, Mexico, Central and South America, the Caribbean, Africa, and Asia.
IMXI
US$21.32
7D
2.2%
1Y
0.09%
VEF
SEK 2.2b
A venture capital firm specializing in early venture, emerging growth and growth capital investments.
VEFF.F
SEK 0.20
7D
0%
1Y
n/a
Ameriprise Financial
US$55.3b
Provides various financial products and services to individual and institutional clients in the United States and internationally.
AMP
US$572.07
7D
1.7%
1Y
62.8%